Wolverine Stack Side Effects: BPC-157 + TB-500 Safety | telos rx
Wolverine stack side effects: BPC-157 and TB-500 in two separate vials
← Back to blog
BPC-157

Wolverine Stack Side Effects: BPC-157 + TB-500 Safety Guide

By TelosRX Editorial Team Updated

Wolverine stack side effects most often reported are mild injection-site reactions, headache, nausea, dizziness, tiredness and flushing. The bigger issue is what is unknown: neither BPC-157 nor TB-500 is FDA-approved, and there are no long-term human studies of either peptide, or of the two taken together.

The Wolverine stack is the nickname for BPC-157 combined with TB-500. Most safety pages cover one peptide at a time. This guide takes the combined view: what each component adds to the list of Wolverine stack side effects, what changes with two peptides, who should avoid the stack, and why the vial itself can be the biggest risk.

Also searched as: wolverine peptide side effects, bpc 157 tb 500 side effects, bpc157 and tb500 side effects, and is the wolverine stack safe.

Wolverine stack side effects at a glance

Here is what has been reported or theorised. Watch the evidence column: most reports come from people describing their own experience, not from placebo-controlled trials.

Effect or risk Linked to Evidence behind it
Redness, swelling, itching at the injection site Both, and the injection itself Most common in user and clinic reports
Headache, nausea, dizziness Both Anecdotal reports
Tiredness or a brief lightheaded feeling Mostly reported with TB-500 Anecdotal reports
Flushing Both Anecdotal reports
Allergic or immune reaction Both, plus impurities Theoretical; incidence not measured
Long-term effects, including cancer questions Both, via angiogenesis Unknown; no long-term human studies

Want a licensed provider to look at your history before you decide? telos rx offers one provider-set BPC-157 + TB-500 plan, supplied as two separate single-ingredient vials and reviewed online without a scheduled appointment.

See if the BPC-157 + TB-500 stack is right for you

BPC-157 side effects: what the research says

BPC-157 is a synthetic 15-amino-acid peptide based on a sequence from a protein found in human gastric juice. Most of its research comes from one group in Zagreb and is overwhelmingly animal and cell work. It is studied for tendon, ligament and muscle healing, gut lining and angiogenesis.

On safety, the evidence is honest about its own limits. A 2025 systematic review in the HSS Journal included 36 studies, of which 35 were preclinical and one was a small human case series. It found that preclinical safety studies showed no adverse effects across several organ systems, but that no clinical safety data were found (Vasireddi et al., 2025). An earlier review of the soft-tissue work reached a similar point: promising animal findings, little human data (Gwyer et al., 2019).

So when people list bpc 157 side effects, such as injection-site irritation, nausea, headache or dizziness, they are mostly repeating reports, not trial results. Our full BPC-157 side effects and safety overview goes deeper on the single-peptide picture.

TB500 side effects: a different molecule, a thinner file

TB-500 is a synthetic peptide based on the actin-binding region of thymosin beta-4, a 43-amino-acid protein found in most cells. Thymosin beta-4 binds and holds G-actin, a building block of the cell's internal scaffolding, and is studied for cell migration, wound repair and angiogenesis. TB-500 is a fragment or analog, not the full protein.

Commonly reported tb500 side effects are injection-site irritation, tiredness, a short "head rush" and headache. The cleanest human safety study did not use TB-500 at all. It gave full-length thymosin beta-4 by IV to healthy volunteers for up to 14 days, and adverse events were infrequent and mild or moderate (Ruff et al., 2010). That is a different molecule, route and time frame, so it cannot be transferred to tb 500 under the skin. Our list of TB-500 side effects: 7 things to know covers this in detail.

What changes with Wolverine stack side effects when you combine two peptides

This is the part single-peptide pages cannot answer. There are no published human studies of BPC-157 and TB-500 used together. That has three practical consequences for Wolverine stack side effects:

  1. Two sets of unknowns, not one. Each peptide has its own thin safety file. Combining them does not cancel the gaps out; it adds them together.
  2. Harder to tell what caused a reaction. If you get a headache or flushing on a stack, there is no way to know from the symptom alone whether BPC-157, TB-500 or the injection itself is responsible.
  3. Shared biology. Both are studied for angiogenesis. Whether combining two compounds studied for the same pathway changes the long-term risk has simply not been tested.

None of this means a reaction is likely. It means no one can give you a number. For how one vial compares with two separate ones, see our sibling guide on a BPC-157 + TB-500 blend in one vial vs two.

Is the Wolverine stack safe? The long-term unknowns

The honest answer to "is the wolverine stack safe" is that the question has not been studied long enough to answer. The open questions include:

  • Long-term use: no study has followed people using either peptide for months or years.
  • Drug interactions: there is no systematic interaction data with blood thinners, immune-suppressing drugs or other peptides.
  • Immune response: peptides can, in theory, trigger an unwanted immune reaction, especially if impurities are present. How often that happens here is not measured.
  • Cancer: the angiogenesis question, covered next.

BPC-157 is not FDA-approved, and TB-500 is not FDA-approved either. In July 2026, the FDA's Pharmacy Compounding Advisory Committee voted to recommend adding both to the list of bulk substances that can be used in compounding, pending FDA rulemaking. That vote was advisory and does not settle any safety question. Since October 28, 2026, a temporary HHS enforcement discretion policy covers each peptide as a single-ingredient compounded product under strict conditions, but not BPC-157 and TB-500 blended in one product; it is not FDA approval either. The telos rx stack is supplied as two separate vials, so neither vial is a blend. See our July 2026 PCAC vote explainer.

Every prescription at telos rx is subject to medical approval by a licensed provider, and approval is not guaranteed. The BPC-157 + TB-500 stack is $133 per month if you are approved.

Start your provider review

Who should avoid the Wolverine stack

Because the safety picture is incomplete, the cautious list is long. Wolverine stack side effects are only part of the decision; some people are screened out before side effects ever come into it.

  • Cancer or a cancer history. Both peptides are studied for new blood vessel growth, which tumors also use. No human study has shown either causes cancer, and none has been long enough to rule it out. People with active cancer or a history of cancer are commonly advised to avoid the stack. Read more in BPC-157 and cancer risk explained.
  • Pregnancy, trying to conceive or breastfeeding. There are no safety data at all, so the stack is not for these groups.
  • Serious allergic reactions to injections or peptide products in the past.
  • Tested athletes. Both peptides are on the WADA Prohibited List at all times, under S0 non-approved substances, and TB-500 is also covered by S2. A prescription does not change that. See our WADA status guide.

Grey-market vials: a side effect you can avoid

Some of the worst Wolverine stack side effects may have nothing to do with BPC-157 or TB-500. Vials sold online as "research use only" are not made for human use. Their identity, strength and sterility are unverified, and the HSS review itself warned that adverse effects are possible due to unregulated manufacturing and contamination.

Risk Grey-market "research" vial Prescription from a licensed pharmacy
Contamination Unknown; not made for human use Compounded by a licensed US pharmacy
Dose Label may not match contents Set by your provider, labelled for you
Right compound No way for you to confirm Prepared against a prescription
Screening None Licensed provider reviews your history
Someone to ask A disclaimer Secure messaging with the care team

If you do look at any certificate of analysis, our guide on how to read a peptide COA explains what a real one shows, and compounded vs unregulated BPC-157 covers the sourcing gap.

How a provider screens for Wolverine stack side effects

At telos rx, the BPC-157 + TB-500 stack is offered as two separate single-ingredient compounded vials, one of each peptide, each taken as a small subcutaneous injection. Your provider sets the dose and schedule and how each one is used. telos rx does not offer TB-500 on its own. Here is how the review works:

  1. You complete an online intake covering cancer history, pregnancy status, medications, allergies and athletic testing.
  2. A US-licensed provider reviews it asynchronously, with no scheduled appointment, and can say no.
  3. If approved, a licensed US pharmacy compounds it and labels it for you.
  4. You report anything unusual through secure messaging with the care team, and your plan can be paused or cancelled.

Dosing questions belong with your provider, but our sibling guide on the Wolverine stack dosage protocol explains how providers think about it, and Wolverine stack benefits covers what people hope the stack does versus what research supports. Full program details are on the BPC-157 + TB-500 stack page.

When to get medical help

Seek urgent care for hives, facial or throat swelling, trouble breathing, chest pain, fainting, or a hot, spreading rash with fever at the injection site. Those are not ordinary Wolverine stack side effects.

Frequently asked questions

What are the most common Wolverine stack side effects?

The most commonly reported Wolverine stack side effects are injection-site redness, swelling or itching, followed by headache, nausea, dizziness, tiredness and flushing. These come mostly from user and clinic reports rather than controlled trials, so how often they happen is not well measured.

Is the Wolverine stack safe?

Nobody can say for certain. BPC-157 and TB-500 are not FDA-approved, there are no long-term human trials of either peptide, and there are none of the two used together. A licensed provider can screen your history and decide whether the stack is appropriate for you, but no one can promise it is safe.

Are BPC-157 + TB-500 side effects worse than taking one peptide?

No human research compares them. Using two peptides means two sets of possible reactions and twice the number of unknowns, and if a reaction happens it can be hard to tell which compound caused it. That is one reason a single provider-set protocol matters.

What are TB500 side effects specifically?

Reported TB500 side effects include injection-site irritation, tiredness, lightheadedness and headache. The best human safety study used full-length thymosin beta-4 given by IV, not TB-500, so it cannot simply be applied to TB-500 injections.

Do Wolverine stack side effects include cancer risk?

No study has shown that BPC-157 or TB-500 causes cancer in people. The concern is theoretical: both are studied for angiogenesis, the growth of new blood vessels, which tumors also rely on. Because long-term studies have not been done, people with cancer or a cancer history are commonly advised to avoid the stack, and a provider decides.

Who should not use the Wolverine stack?

People with active cancer or a cancer history, anyone who is pregnant, trying to conceive or breastfeeding, people with a history of serious allergic reactions to injections, and competitive athletes subject to drug testing are usually screened out or asked to pause. A licensed provider makes the final decision.

Can research-grade vials cause their own side effects?

Yes, potentially. Grey-market vials labelled research use only are not made for human use, and their purity, sterility and dose are unverified. Contamination, the wrong amount or the wrong compound can cause problems that have nothing to do with the peptides themselves.

Get the combined view from a licensed provider, not a forum thread. One online intake, a provider-set protocol, and a licensed US pharmacy if you are approved.

See if the BPC-157 + TB-500 stack is right for you

This article is for general education and is not medical advice. BPC-157 is not FDA-approved, and TB-500 is not FDA-approved, for any use. Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness or quality. All prescriptions are subject to medical approval by a licensed provider; approval is not guaranteed. Both peptides are prohibited by WADA at all times. telos rx is an online-first, asynchronous telehealth service, and medications are compounded by a licensed US pharmacy. Individual experiences vary.

Related research

Compounded medications are compounded, not FDA-approved. Prescriptions are never automatic or guaranteed. TelosRX operates under LegitScript-certified telehealth standards as an online-first, asynchronous telehealth service.

Read more from TelosRX